Crescita Therapeutics Inc. (CTX.TO)
CAD 0.57
(1.79%)
CAD 0.57
(1.79%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 24.59 Million CAD | -13.64% |
| 2022 | 28.48 Million CAD | -1.52% |
| 2021 | 28.92 Million CAD | 7.8% |
| 2020 | 26.83 Million CAD | -0.02% |
| 2019 | 26.83 Million CAD | -2.64% |
| 2018 | 27.56 Million CAD | 22.16% |
| 2017 | 22.56 Million CAD | -47.55% |
| 2016 | 43.01 Million CAD | 3521.04% |
| 2015 | 1.18 Million CAD | -27.38% |
| 2014 | 1.63 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 22.95 Million CAD | -4.64% |
| 2024 Q1 | 24.06 Million CAD | -2.15% |
| 2023 FY | 24.59 Million CAD | -13.64% |
| 2023 Q1 | 27.84 Million CAD | -2.26% |
| 2023 Q2 | 26.52 Million CAD | -4.71% |
| 2023 Q3 | 25.37 Million CAD | -4.37% |
| 2023 Q4 | 24.59 Million CAD | -3.05% |
| 2022 Q3 | 27.71 Million CAD | -0.3% |
| 2022 Q1 | 29.41 Million CAD | 1.7% |
| 2022 FY | 28.48 Million CAD | -1.52% |
| 2022 Q2 | 27.79 Million CAD | -5.51% |
| 2022 Q4 | 28.48 Million CAD | 2.79% |
| 2021 Q1 | 28.69 Million CAD | 6.95% |
| 2021 Q4 | 28.92 Million CAD | 3.21% |
| 2021 Q3 | 28.02 Million CAD | 1.02% |
| 2021 Q2 | 27.74 Million CAD | -3.33% |
| 2021 FY | 28.92 Million CAD | 7.8% |
| 2020 Q2 | 23.47 Million CAD | -11.78% |
| 2020 Q1 | 26.6 Million CAD | -0.86% |
| 2020 Q4 | 26.83 Million CAD | -3.45% |
| 2020 Q3 | 27.79 Million CAD | 18.4% |
| 2020 FY | 26.83 Million CAD | -0.02% |
| 2019 Q4 | 26.83 Million CAD | -17.52% |
| 2019 Q2 | 31.53 Million CAD | 9.03% |
| 2019 FY | 26.83 Million CAD | -2.64% |
| 2019 Q1 | 28.92 Million CAD | 4.93% |
| 2019 Q3 | 32.53 Million CAD | 3.18% |
| 2018 Q1 | 26.07 Million CAD | 15.57% |
| 2018 FY | 27.56 Million CAD | 22.16% |
| 2018 Q4 | 27.56 Million CAD | 11.24% |
| 2018 Q3 | 24.78 Million CAD | 3.86% |
| 2018 Q2 | 23.85 Million CAD | -8.51% |
| 2017 Q3 | 31.21 Million CAD | -12.2% |
| 2017 Q2 | 35.55 Million CAD | -3.91% |
| 2017 FY | 22.56 Million CAD | -47.55% |
| 2017 Q1 | 37 Million CAD | -13.99% |
| 2017 Q4 | 22.56 Million CAD | -27.72% |
| 2016 Q1 | 34.14 Million CAD | 2773.74% |
| 2016 Q4 | 43.01 Million CAD | -14.31% |
| 2016 Q3 | 50.19 Million CAD | 62.46% |
| 2016 Q2 | 30.89 Million CAD | -9.49% |
| 2016 FY | 43.01 Million CAD | 3521.04% |
| 2015 FY | 1.18 Million CAD | -27.38% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q4 | 1.18 Million CAD | 0.0% |
| 2014 FY | 1.63 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | 97.067% |
| Avicanna Inc. | 21.97 Million CAD | -11.956% |
| Avant Brands Inc. | 82.55 Million CAD | 70.203% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | 32.976% |
| Knight Therapeutics Inc. | 945.49 Million CAD | 97.398% |
| MediPharm Labs Corp. | 63.93 Million CAD | 61.528% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | 91.758% |
| Canopy Growth Corporation | 1.3 Billion CAD | 98.108% |
| Willow Biosciences Inc. | 6.67 Million CAD | -268.62% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | 90.608% |